Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Neuroprotection in Pediatric CPB
NCT00556361Phase 2Completed
- Sponsor
- Arkansas Children’s Research Institute
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in central nervous system injury (CNSI), sponsored by Arkansas Children’s Research Institute. Started Jul 2004; status: completed.
02
Drugs
ketamine
03
Conditions
central nervous system injury (CNSI)
Beyond the preview
Go deeper on NCT00556361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556361.